K. Tupek

Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis

R. Kusec, D. Rahelić, A. Livun, 2018, Wiener klinische Wochenschrift.

Neutral effect of Glioma-associated oncogene-1 expression on survival in myelofibrosis

A. Livun, M. Lucijanić, V. Pejsa, 2019, Wiener klinische Wochenschrift.

AML in remission, originating from MDS-RARS-T, expands the underlying JAK2 V617F mutated clone

A. Livun, V. Pejsa, Ž. Prka, 2020, Molecular and experimental biology in medicine.

THE ASSOCIATION OF VIABLE MONONUCLEAR CELLS AND CFU-GM WITH TIME OF HEMATOPOIETIC ENGRAFTMENT

A. Livun, K. Tupek, 2018 .

Epigenetic drug 5-azacytidine impairs proliferation of rat limb buds in an organotypic model-system in vitro

L. Serman, G. Jurić-Lekić, F. Bulić-Jakuš, 2013, Croatian medical journal.

Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival

G. Aralica, A. Livun, M. Lucijanić, 2017, Leukemia & lymphoma.

Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis

A. Livun, M. Lucijanić, V. Pejsa, 2018, Annals of Hematology.